Biography

Dr. Houry obtained his MSc (1991) and PhD (1996) from Cornell University and then did his postdoctoral training at the Sloan-Kettering Institute (1996-1997) in New York City and at the Max-Planck-Institute for Biochemistry (1997-2000) in Munich, Germany. He is interested in the general area of cellular stress responses and the role of molecular chaperones and ATP-dependent proteases in these responses. Dr. Houry is also heavily involved in the general scientific community in several capacities.

Biography

Dr. Singh teaches courses aimed at improving data and statistical literacy for undergraduate and graduate students in the Department of Immunology. Her pedagogical interests include incorporation of active learning techniques, including video-based modules, into classrooms to promote experiential learning for students. She is also very interested in building multidisciplinary collaborations for promotion of student learning in both online and traditional classrooms.

Biography

Stephanie provides strategic planning for the Knowledge Engagement portfolio’s initiatives. With over 10 years of experience in research, teaching, student advising, and strategic research support, Stephanie seeks creative, meaningful and inclusive ways to support and expand knowledge engagement and research assessment across the University of Calgary.

Biography

Dr. Jane Batt is a Respirologist and Scientist at St. Michael’s Hospital and Associate Professor of Medicine, University of Toronto. Her research focuses on delineating the molecular mechanisms underlying the development of skeletal muscle atrophy and dysfunction in chronic respiratory illness and acute injury. Dr Batt is also the Medical Director of the SMH Tuberculosis (TB) Clinic and in collaboration with other SMH scientists is developing a digital database of all patients seen in the TB clinic to enable collaborative clinical research projects. The database consists of variables (clinical, demographic, imaging, lab values, visits/admissions) that are derived from clinical dictations using natural language processing tools and electronic medical records, with digital dashboard navigation capabilities.

Biography

Since joining Shift Health in 2011, Adrian has supported dozens of organizations in developing corporate, research and product strategies, assessing health technologies and drug products, and attracting capital. As a member of the Leadership Team, Adrian helps shape and advance our firm’s corporate strategy. Prior to Shift Health, he completed his MSc and PhD in Neuroscience at Western University.

Biography

Rozee started her career as an HEOR (health economic and outcome research) consultant creating curated evidence for pharmaceutical companies to help inform Health Technology Assessments and other market access related activities. In her current role, she is also a product owner responsible for supporting a healthcare software product development.

Biography

Julian is a consultant at BCG in the Boston office. Prior to joining BCG, Julian obtained his PhD in chemistry from the University of Toronto, where his research focused on developing microfluidic tools for diagnostics. During his time at BCG, Julian has worked on healthcare and industrial goods focused cases, with a specific focus on operations.

Biography

Amra Das is part of the Strategy and Consulting Practice at Accenture and is passionate about health innovation. She graduated from the University of Toronto with a Bachelor’s in Neuroscience and Cell & Molecular Biology and her Master’s in Health Informatics. From here, she’s worked with clients across Canada with projects in long-term care, primary care, covid testing, virtual care, and more.

Biography

Alex is a Regulatory Affairs Project Manager at AstraZeneca Canada, working primarily in the cardiovascular, renal, and oncology therapeutic areas. Previously, Alex worked in Regulatory Affairs at Janssen. Alex completed a BSc in Toxicology and an MSc in Pharmacology at the University of Toronto. Alex also studied Regulatory Affairs and Quality Operations at Seneca College.

Biography

Sugee is currently a Regulatory Affairs Associate at GlaxoSmithKline in Mississauga Ontario. She graduated with a BSc in Pharmaceutical Chemistry at the University of Guelph and attended Seneca for a post-graduate certificate in RAQC. She's currently continuing to learn and develop her skills in Regulatory Affairs in the Pharmaceutical industry.

Biography

Mathieu is a Regulatory Affairs Manager at Janssen, the pharmaceutical division of Johnson and Johnson. In his role, he is responsible for developing and implementing regulatory strategies to secure the approval by Health Canada of new oncology therapies. Mathieu's academic background is in cancer biology - he received a PhD in Cellular and Molecular Medicine from the Univeristy of Ottawa.

Biography

Monica is a pharmacist with over 25 years of experience, most recently as a senior executive at Amgen Canada. Currently she is the President COMPASS Medical Affairs and helps biopharmaceutical companies solve complex problems and build highly valued teams. Monica co-founded Medical Affairs Canada with a focus on talent development and providing enterprise strategic services.

Biography

Dr. Tara Christie has 15 years experience in university administration, specifically program development and management. Tara is a central connection at the University of Calgary for graduate recrutiment, research communication skills training, and the incorporation of experiential learning and critical reflection into the graduate experience.

Biography

Lucy Harrison lives in the unceded territory of the Coast Salish Peoples in Vancouver, BC. Lucy is a Project Manager with the Impact Assessment Agency of Canada, responsible for managing large environmental assessments through federal regulatory processes. The driving force for her career has been saying ‘yes’ to new and exciting opportunities, however strange and scary they sounded!

Biography

Olga Pena is a passionate scientist with over 15 years of combined biomedical research & management experience, which she now applies to science & health policy decision-making. She possesses a strong track record based on scientific excellence & leadership skills. Olga is a founder and supporter of grassroots organizations, commited to lead with kindness and empathy towards an equitable world.

Biography

Hayet Laggoune is a senior Analyst at the Impact Assessment Agency of Canada. She holds a B.Sc, a M.A.Sc in renewable energies from the University of Constantine and a Ph.D from University of Burgundy-France in Electrical Engineering. Prior to joining the government, Hayet was a professor at Universitas Gunadarma, and then a part time professor at the University of Ottawa, UQAM and UQO.

Biography

Dr. Amy Sharma, PhD, DABT is a regulatory toxicologist strategy leader at Pfizer, NYC. She leads development of several small, large and vaccine based therapy programs, with a deep expertise on global nonclinical regulatory stratgey. Her areas of focus include mRNA therapies, infectious disease, oncology and immunology. Dr. Sharma previously held senior positions at both Amgen and Genentech.

Biography

Dr Shehzad Iqbal is a Sr. Medical Director at Moderna and comes from an extensive academic and industry-based Research & Development (R&D) background. As an immunologist he has focused on infectious diseases with a primary interest in vaccine development. He currently leads Moderna's Medical/Clinical initiatives in Canada to bring mRNA based vaccines and therapeutic interventions to patients.

Biography

Ronan Rogers is a Canadian medical lead and MSL manager for neuromuscular/rare disease at Biogen. He is highly proficient in developing interpersonal relationships that help facilitate high level medical and scientific engagements. He is also very involved in advancing discourse between academia, industry and government so that data can be translated into optimized outcomes for all patients.

Biography

Elli completed her B.Sc. and B.Ed. at Brock University. Following her undergraduate thesis studying spinal cord regeneration, Elli found her passion in CRISPR gene editing and regenerative medicine. She completed her M.Sc. in Pharmaceutical Sciences at the University of Toronto and is now a Research Associate on the Assay Development team at BlueRock Therapeutics, a cell and gene therapy company.

Biography

Ronald Zahoruk is a pharmaceutical professional who has worked in industry since 2011 across the drug development cycle in multiple business functions, including medical writing, corporate strategy, project management and business management. Ronald is currently a Senior Manager, Medical Writing at PPD, a renowned global CRO, and a Flex-time PhD student at UofT's Leslie Dan School of Pharmacy.

Biography

Chantel in a Senior Medical Writer at Apothecom, where she leads the communication of important medical information to doctors and patients, translates complex scientific data into academic publications and presentations, and contributes to the scientific strategy of major biotech and pharmaceutical companies (amongst other things).

Biography

Laurel Oldach is a science writer at ASBMB Today, the news magazine of the American Society for Biochemistry and Molecular Biology, covering research news, biotechnology, science careers and life in the lab. She's been at ASBMB since shortly after earning her Ph.D. in pharmacology at Johns Hopkins in 2018.

Biography

Sridevi obtained her PhD in Biomedical Sciences at SUNY, Albany. Post-graduation, she studied human intestinal organoids at the University of Maryland Baltimore. She relocated to Toronto in December 2020 and after a brief internship at Sanofi Pasteur Medical Affairs, she took on her current role as an Associate Medical Writer at McCann Health wherein she supports Immuno-oncology medical affairs.

Biography

After having completed a BSc, PhD, and post-doctoral training, Dr. Seet joined GlaxoSmithKline in 2006 holding various positions. During this time, he completed his MBA at the University of Toronto. In 2014, Bruce moved to Sanofi Pasteur as a Director, Medical Affairs where he continues to work. Bruce founded and serves as the President/CEO of the Science to Business Network (www.s2bn.org).